vs
Side-by-side financial comparison of OppFi Inc. (OPFI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
OppFi Inc. is the larger business by last-quarter revenue ($85.6M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). OppFi Inc. runs the higher net margin — 19.7% vs -38.1%, a 57.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 5.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 16.3%).
OppFi Inc. is a US-headquartered financial technology firm that provides responsible, accessible financial solutions including installment loans, credit-building tools and related support services to consumers underserved by traditional banking institutions, prioritizing fair terms to help users boost their long-term financial wellness.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
OPFI vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $85.6M | $83.1M |
| Net Profit | $16.8M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 36.1% | -4.1% |
| Net Margin | 19.7% | -38.1% |
| Revenue YoY | 5.9% | 20.2% |
| Net Profit YoY | 400.3% | -27.9% |
| EPS (diluted) | $1.48 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $85.6M | $76.4M | ||
| Q3 25 | $104.6M | $83.3M | ||
| Q2 25 | $100.2M | $79.2M | ||
| Q1 25 | $90.8M | $69.2M | ||
| Q4 24 | $80.8M | $68.2M | ||
| Q3 24 | $91.2M | $58.4M | ||
| Q2 24 | $86.3M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $16.8M | $-29.8M | ||
| Q3 25 | $41.6M | $-21.4M | ||
| Q2 25 | $-20.8M | $-19.6M | ||
| Q1 25 | $-11.4M | $-24.7M | ||
| Q4 24 | $-5.6M | $-18.9M | ||
| Q3 24 | $4.3M | $-21.0M | ||
| Q2 24 | $3.1M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 36.1% | -40.6% | ||
| Q3 25 | 46.3% | -27.8% | ||
| Q2 25 | 44.7% | -28.0% | ||
| Q1 25 | 46.8% | -39.7% | ||
| Q4 24 | 30.5% | -28.9% | ||
| Q3 24 | 38.5% | -38.4% | ||
| Q2 24 | 34.2% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 19.7% | -39.1% | ||
| Q3 25 | 39.8% | -25.7% | ||
| Q2 25 | -20.7% | -24.7% | ||
| Q1 25 | -12.5% | -35.8% | ||
| Q4 24 | -6.9% | -27.6% | ||
| Q3 24 | 4.7% | -35.9% | ||
| Q2 24 | 3.6% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $1.48 | $-0.54 | ||
| Q3 25 | $0.77 | $-0.38 | ||
| Q2 25 | $-0.78 | $-0.35 | ||
| Q1 25 | $-0.48 | $-0.45 | ||
| Q4 24 | $-0.11 | $-0.34 | ||
| Q3 24 | $0.21 | $-0.40 | ||
| Q2 24 | $0.16 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.5M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $58.5M | $347.7M |
| Total Assets | $754.1M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $49.5M | $286.5M | ||
| Q3 25 | $45.5M | $294.3M | ||
| Q2 25 | $45.2M | $302.7M | ||
| Q1 25 | $58.0M | $316.2M | ||
| Q4 24 | $61.3M | $333.7M | ||
| Q3 24 | $44.8M | $196.8M | ||
| Q2 24 | $46.6M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $58.5M | $365.9M | ||
| Q3 25 | $49.4M | $380.3M | ||
| Q2 25 | $13.4M | $385.8M | ||
| Q1 25 | $22.6M | $389.2M | ||
| Q4 24 | $32.8M | $402.2M | ||
| Q3 24 | $34.9M | $241.2M | ||
| Q2 24 | $18.6M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $754.1M | $508.1M | ||
| Q3 25 | $720.6M | $511.5M | ||
| Q2 25 | $673.4M | $513.1M | ||
| Q1 25 | $640.1M | $519.4M | ||
| Q4 24 | $641.2M | $534.0M | ||
| Q3 24 | $619.3M | $374.1M | ||
| Q2 24 | $573.1M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $401.3M | — |
| Free Cash FlowOCF − Capex | $382.2M | — |
| FCF MarginFCF / Revenue | 446.6% | — |
| Capex IntensityCapex / Revenue | 22.3% | — |
| Cash ConversionOCF / Net Profit | 23.82× | — |
| TTM Free Cash FlowTrailing 4 quarters | $652.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $401.3M | $-10.3M | ||
| Q3 25 | $105.1M | $-6.6M | ||
| Q2 25 | $95.6M | $-15.0M | ||
| Q1 25 | $83.7M | $-17.0M | ||
| Q4 24 | $323.8M | $-32.4M | ||
| Q3 24 | $77.6M | $-18.8M | ||
| Q2 24 | $77.3M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $382.2M | $-12.2M | ||
| Q3 25 | $99.9M | $-9.5M | ||
| Q2 25 | $91.0M | $-17.8M | ||
| Q1 25 | $79.3M | $-18.8M | ||
| Q4 24 | $310.8M | $-33.6M | ||
| Q3 24 | $73.7M | $-19.0M | ||
| Q2 24 | $74.7M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 446.6% | -15.9% | ||
| Q3 25 | 95.6% | -11.4% | ||
| Q2 25 | 90.8% | -22.5% | ||
| Q1 25 | 87.4% | -27.2% | ||
| Q4 24 | 384.6% | -49.2% | ||
| Q3 24 | 80.8% | -32.6% | ||
| Q2 24 | 86.6% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 22.3% | 2.4% | ||
| Q3 25 | 5.0% | 3.4% | ||
| Q2 25 | 4.6% | 3.5% | ||
| Q1 25 | 4.8% | 2.7% | ||
| Q4 24 | 16.1% | 1.7% | ||
| Q3 24 | 4.3% | 0.4% | ||
| Q2 24 | 3.0% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 23.82× | — | ||
| Q3 25 | 2.52× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 18.19× | — | ||
| Q2 24 | 25.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPFI
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |